The inhibitor of NF-κB signaling, disulfiram, which is used clinically in the treatment of alcohol-dependent tissue damage, has also been shown to inhibit TGFβ-induced EMT and primary tumor growth of breast cancer cell models [213]. The gene discussed is NFKB1; the disease is neoplasm.